The Commission proposes to do so by bringing in a revised Radio Equipment Directive for…
IIPRD has been successfully conducting several symposiums over the years on different Intellectual Property (IP) aspects. One of them is the upcoming three-day symposium on Pharmaceutical, Biotechnology &Chemical Patent Laws with focus on Preparation, Prosecution and Litigation in U.S., Europe, China, and India. While the symposium is being organized in Mumbai from 18th – 20th November 2019,it will be held in Hyderabad from 19th – 21st November, 2019. Along with IIPRD and Khurana & Khurana, Advocates and IP Attorneys (India), Sughrue Mion PLLC (US), and Hamm &Wittkopp Patentanwalte (Germany) are among the organizers.
With speakers like ChidIyer-Partner of International Law Firm of SughrueMion, TarunKhurana who has over 17 years of experience in a broad range of IP subject matters and is the Co-Founding Partner and Patent Attorney of Khurana & Khurana , Dr.Alexander Wittkopp is a Partner at Hamm&Wittkopp Patent Attorneys, based in Hamburg (Germany), Michael R. Dzwonczyk a Partner at SughrueMion and has about 22 years of experience in IP industry ,Renita S. Rathinam – a Partner in the Washington, D.C. office of McNeely, Hare & War LLP , Mr. Grant Shackelford – Associate at SughrueMion and Mr. Mark Boland who has successfully represented a variety of companies in the U.S., Asia and Europe as lead counsel in numerous Patent Litigations before federal district courts, one cannot afford to miss same.
This event turns out to be great opportunity for In-house Counsels, Life Science Companies, IP Management Teams, Research & Development Scientists, Patent Agents & Attorneys in the field of Practice, Patent Litigators, Professionals in Legal-Business domain related to Pharma, Biotech and Chemical Industry.
Fee per delegate is INR 15,000 for Indians and is USD 300 for foreign applicants.
For more details about profiles of partners, programme outline, speakers, why and how to apply, please see: https://www.iiprd.com/three-days-symposium-on-pharmaceutical-biotechnology-chemical-patent-laws-2019/